secwatch.observer — SEC 8-K summary
======================================

Issuer:     Twist Bioscience Corp (TWST)
CIK:        0001581280
Form:       8-K
Filed at:   2022-02-04T23:59:59+00:00
Accession:  0001104659-22-011724
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Twist Bioscience Q1 FY2022: revenue $42M (+49% YoY), orders up 48%, raises FY guidance
--------------------------------------------------------------------------------

- Revenue of $42.0M (up 49% from $28.2M YoY); orders of $49.6M (up 48% from $33.6M).
- Net loss $45.6M ($0.91 per share) vs $32.9M ($0.72 per share) in prior year.
- Cash, cash equivalents and investments $408.7M as of Dec 31, 2021; shipped to ~1,800 customers.
- Raised fiscal 2022 revenue guidance; specific numbers not provided in the press release excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1581280/000110465922011724/0001104659-22-011724-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1581280/000110465922011724/tm224740d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-011724

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer